牛皮患者的基线病理性肝功能测试支持系统治疗的指示,而不是反对它的原因:现实世界的分析
Frederik Krefting1, Cosima Scheib1, Sven Benson2
1Department of Dermatology, Venereology and Allergology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Psoriasis (Auckland, N.Z.)
|March 6, 2025
概括
系统性牛皮治疗对于肝功能测试 (LFT) 升高的患者来说是安全的. 实践数据显示,这些治疗可以改善肝酶,而不会增加肝纤维化风险.
科学领域:
- 皮肤病学 皮肤病学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮患者患肝病的风险增加.
- 升高的肝功能测试 (LFTs) 可以阻止全身牛皮治疗的开始.
- 系统疗法是有效的,但引起了对潜在的肝损伤的担忧.
研究的目的:
- 提供现实世界的证据,证明系统性牛皮治疗在患有高LFTs的患者中的安全性.
- 评估全身治疗对牛皮患者肝功能和纤维化的影响.
- 为了解决医生由于基线LFTs开始全身治疗的不情愿.
主要方法:
- 对278名接受secukinumab,ixekizumab,adalimumab或apremilast治疗的牛皮患者进行了回顾性分析.
- 队列被分为具有正常或升高基线LFTs的子组.
- 在基线,3个月和6个月监测AST,ALT,GGT和FIB-4分数.
主要成果:
- 基线LFT升高的患者的PASI得分更高,男性更常见,代谢综合征更常见.
- 在正常基线LFT组中,LFT或FIB-4没有显著变化.
- 在升高的基线LFT组中,LFT显著下降,而FIB-4没有显著变化.
- 药物存活率,停药率和PASI-75反应在子组之间是相似的.
结论:
- 牛皮的全身疗法对于基线LFTs升高的患者来说是安全的,并且可能有益.
- 这些治疗不构成一般风险,可以被视为改善肝脏健康的机会.
- 现实世界的数据支持使用secukinumab,ixekizumab,adalimumab或apremilast,尽管基线LFT异常.
相关概念视频
01:30Serum Laboratory Studies, Stool Test, Breath Test
296
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
296
01:30Liver Physiology
404
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
404
01:27Liver Histology
525
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Hepatocytes perform a variety of essential functions. They secrete...
525
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
63
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
63
01:29Chronic Pancreatitis II: Collaborative Care
56
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
56